9.1 C
New York
Sunday, December 5, 2021

Johnson & Johnson Research Report

About Company

Johnson & Johnson, also known as J&J, is a US-based international corporation that was established in 1886. Johnson & Johnson is involved in developing drugs/medicines, healthcare equipment, and packaged customer products.

The common stocks of J&J are constituents of the Dow Jones Industrial Average (DJIA) index. The organization enjoys 36th rank on the Fortune 500 list of the biggest US-based conglomerates in terms of gross revenue released in 2021.

J&J ranks among the worthiest organizations in the world, and it is one of the just two US-based firms that have a major credit rating of AAA, surpassing that of the government of the US.

The head office of Johnson & Johnson is located in New Brunswick, New Jersey. The customer business segment is based in Skillman, New Jersey. The firm is made up of approximately 250 ancillary firms with a presence in sixty nations and goods marketed in more than 175 nations.

The global sales of Johnson & Johnson amounted to the US $82.6 billion for the 2020 calendar year. J&J’s brands comprise many familiar names of first-aid provisions and drugs. The most famous customer goods manufactured by Johnson & Johnson include the following:

  • Tylenol drugs 
  • The Band-Aid Brand strip of dressings 
  • Neutrogena cosmetics (skin and beauty products) 
  • Baby products by Johnson 
  • Acuvue contact lenses 
  • Clean & Clear face wash  

The pharmacy division of the company is known as Janssen Pharmaceutica.

To Which Industry Type Does Johnson & Johnson Belong?

Johnson & Johnson belongs to the following industries:

  • Healthcare equipment 
  • Pharmacy 
  • Customer healthcare

When was Johnson & Johnson established?

The company was set up in 1886 January, one hundred thirty-five years back in New Brunswick, New Jersey, US.

Who are the founders of Johnson & Johnson?

The founders of Johnson & Johnson are 

  • James Wood Johnson
  • Robert Wood Johnson I
  • Edward Mead Johnson

Which area does Johnson & Johnson serve?

The company has a global client base.

Who served as Chairmen of the company over the years?

The following individuals served as chairmen of the company over the years:

  • 1887–1910 – Robert Wood Johnson I 
  • 1910–1932 – James Wood Johnson 
  • 1932–1963 – Robert Wood Johnson II 
  • 1963–1973 – Philip B. Hofmann 
  • 1973–1976 – Richard B. Sellars 
  • 1976–1989 – James E. Burke 
  • 1989–2002 – Ralph S. Larsen 
  • 2002–2012 – William C. Weldon 
  • 2012–present – Alex Gorsky  

Johnson & Johnson Management

Alex Gorsky (Chairman and CEO)

Alex Gorsky serves as the Chief Executive Officer and Chairman of the Board of Directors of the company. He is one of the 7 honchos who had the opportunity of serving the firm in dual positions from the time the listing of J&J took place in 1944 on the NYSE.

Gorsky commenced his professional stint with J&J when he joined as a salesperson in 1988 with Janssen Pharmaceutica. Throughout the following thirty years, he progressed via roles of a growing task in promotion, sales, as well as supervision, concluding in being nominated in 2012 as the Chief Executive Officer and Chairman of the organization.

Under the able guidance of Gorsky, J&J has both preserved the firm’s 133-year heritage of supplying answers to the most pressing unfulfilled healthcare requirements of the world and kept on specifying outlook when it is a question of the goal-oriented invention and eco-friendly expansion for all the stakeholders.

Throughout his stint, J&J has turned into a stellar worldwide pharmaceutical manufacturing firm and also the top sponsor of the sector in the domain of R&D. The healthcare equipment segment is at the vanguard of implementing forward-looking technology to eye care, operations, orthopedics, and treatment solutions. The Customer Health sector keeps on transforming its set of both emblematic legacy brands and ground-breaking leaps in skincare and personal care.

Beyond J&J, Gorsky’s authority has forged both the healthcare setting and the larger commercial fraternity via his activities as a dynamic association of the Business Roundtable and the Business Council. A lifetime patron of variety and addition and champion of ex-serviceman’s concerns, Gorsky presently is a part of the BoD of IBM and the Travis Manion Foundation.

Following the completion of undergrad schooling with the US Military Academy, West Point, NY, Gorsky had been a part of the US Army for 6 years. Alex got his Master of Business Administration degree in 1996 from the University of Pennsylvania Wharton School. Gorsky is happily married to Patricia, his spouse, for over three decades, and they have one son whose name is Nick.

Joaquin Duato (Vice Chairman of the Executive Committee)

Duato is an internationally thinking, goal-oriented corporate leader and a part of the Executive Committee for J&J, the biggest and most sophisticated healthcare services firm in the world. His stint with Johnson & Johnson spans over thirty years and covers various commercial domains, characteristics, and activities. In his present position, Duato offers tactical guidance for the Customer Health and Pharmaceutical segments (a US $60 billion collection) and supervises the Technology, Worldwide Supply Chain, and Health and Wellness groups.

Duato has a Master of Business Administration degree from ESADE, Barcelona, Spain. He also has a Master of International Management (MIM) degree from Thunderbird, Phoenix, Arizona. As a proponent of the right to health training, Joaquin counsels Master of Business Administration aspirants at universities throughout the world and frequently delivers lectures on management at educational institutes and chambers of commerce round-tables.

Paul Stoffels (Chief Scientific Officer and Vice Chairman of the Executive Committee)

Paul is a farsighted leader who motivates and propels evolving inventions to add years of living and qualitative life to countless individuals across the world.

Stoffels learned Medicine at the University of Antwerp and the University of Diepenbeek in Belgium and Tropical Medicine and Infectious Diseases at the Institute of Tropical Medicine in Antwerp, Belgium. Paul commenced his professional life as a doctor of medicine in Africa, concentrating on tropical illnesses and HIV investigation.

Which are the subsidiaries of J&J?

The subsidiaries of J&J are the following:

  • Actelion
  • Acclarent
  • DePuy Synthes
  • Cilag
  • Janssen Biotech
  • Ethicon
  • Janssen Vaccines
  • Janssen Pharmaceuticals
  • McNeil Consumer Healthcare
  • Johnson & Johnson Vision
  • Synthes
  • Mentor
  • Tibotec

Operational segments of J&J

The commercial operations of the firm are split into three key segments: 

  • Healthcare equipment 
  • Pharmacy 
  • Customer Health 

These sectors chipped in 28%, 55%, and17%, correspondingly, of the organization’s gross revenue in 2020.

Johnson & Johnson Operational Segments

J&J Operational Segments


The Pharmaceutical division of J&J concentrates on six remedial domains: 

  • Communicable Diseases (AIDS/HIV); 
  • Immunology – psoriasis, inflammatory bowel disease (colitis), and rheumatoid arthritis; 
  • Oncology (hematologic disorders and cancer of the prostate gland); 
  • Neuroscience (schizophrenia, neurodegenerative diseases, and mood disorders); 
  • Cardiovascular, Retina, and Metabolism (polygenic disease and thrombosis), and Pulmonary Hypertension (Pulmonary Arterial Hypertension).

Healthcare Equipment 

The Cardiovascular and Specialty Solutions cluster comprises electrophysiology goods that detect and cure cardiac arrhythmias; equipment utilized in the intervention of ischemic and hemorrhagic stroke occurring within a blood vessel; solutions concentrating on breast restoration and aesthetics, and ENT (ear, nose, and throat) operations.

The orthopedics collection consists of areas of expertise such as injury, joint renovation surgery, craniomaxillofacial, extremities, athletics medication, and spinal surgical procedure, over and above the VELY digital operation set.

The operation list comprises sophisticated operative interventions and solutions like stapling machines, surgical seams/stitches, upgraded hemostats, and power equipment, together with treatment excision, computerized solutions, and operative robotics.

The J&J Vision collection comprises intraocular lenses, contact lenses, machine-controlled intervention for keratoconjunctivitis sicca (dry eyes), as well as 4 trademark products of laser vision rectification solutions.

Customer Healthcare

The Customer Healthcare Business Segment consists of a wide variety of goods concentrated on individual healthcare utilized in the over-the-counter (OTC) drugs, beauty/skincare, oral care, child care, injury care, and women’s health marketplaces. It consists of beauty/skincare, personal care, and essential health categories.

The beauty/skincare group comprises tailored skincare evaluations, cure for skin disease, acne, and aging symptoms, and moisturizers, cleansing agents, and sun creams.

The personal-care family consists of drugs for pain control, quitting smoking, hypersensitivity, anti-diarrhetic, topical decongestants, antacids, and cough and cold medicines.

The vital healthcare family comprises goods for oral hygiene, injury care, women, and child care.

Head office and New Brunswick, NJ upscaling

Traditionally, the organization has been situated on the Delaware and Raritan Canal, New Brunswick, NJ. However, J&J thought about shifting its head office away from New Brunswick during the 60s. Finally, it resolved to remain in that particular borough once the civic administration vowed to renovate the business district by razing dilapidated structures and building fresh ones.

Though New Brunswick got rid of numerous age-old constructions, comprising the former campus of Rutgers University, and the majority of its momentous business city district to the overhaul endeavor, the upscaling drew citizens to New Brunswick once again.

Ecological track record of J&J

J&J has fixed various optimistic targets for maintaining the organization eco-friendly and achieved the 3rd position among the biggest US-based firms as laid down by the “Green Rankings” by Newsweek.

Certain instances are the step-down in water consumption, throwaway, and power consumption, and an enhanced degree of clarity. 

J&J decided to modify the boxing of plastic bottles utilized in the fabrication procedure, converting their packing of fluids to non-polyvinyl chloride bottles. 

The conglomerate functions with the EPA (the United States Environmental Protection Agency) National Environmental Performance Track plan and the Climate Northwest Initiative.

As an affiliate of the countrywide Green Power Partnership, J&J runs the biggest solar energy producer in the state of Pennsylvania at its location in Spring House, PA.

Corporate Governance

The present members constituting the board of directors of the company for 2020 are the following: 

  • Mary C. Beckerle
  • Alex Gorsky 
  • Ian E. L. Davis 
  • D. Scott Davis 
  • Jennifer A. Doudna 
  • Anne M. Mulcahy
  • Mark B. McClellan 
  • Charles Prince 
  • William D. Perez 
  • Marillyn A. Hewson 
  • Eugene Washington 
  • Ronald A. Williams
  • Hubert Joly 
  • Mark Weinberger

Presently, the members comprising the J&J Executive Committee are the following: 

  • Peter Fasolo 
  • Joseph Wolk (the chief financial officer of the organization since 2014)
  • Thibaut Mongon 
  • Ashley McEvoy 
  • Michael Sneed 
  • Paul Stoffels 
  • Michael Ullmann 
  • Jennifer Taubert 
  • Kathy Wengel

On 2nd July 2018, J&J’s pharmaceuticals division chief, Joaquin Duato, got the appointment of the executive committee vice-chairman.

Johnson & Johnson Financial Performance

Q3 comprehensive financial results

(Figures are in million US $, other than Earnings Per Share)

Johnson & Johnson Financial Performance

Financial performance highlights

  • Overall sales increase of 10.7% to US $23.3 billion with functional development of 9.9% as well as modified functional development of 10.6%
  • The Firm is enhancing the 2021 Whole-Year regulation
  • Earnings per share (EPS) of US $1.37, rising 3.0%, and adjusted EPS of US $2.60, rising 18.2%

Johnson & Johnson Stock Performance

The common stocks of the company are traded on the NYSE with the ticker symbol JNJ. Besides, the stock is a component of the following indices:

  • Standard & Poor 100 
  • Dow Jones Industrial Average
  • Standard & Poor 500

On November 3, 2021, Johnson & Johnson ended trading with NYSE at US $165.06 at 4:00 pm Eastern Daylight Time (EDT).

Johnson and Johnson stock performance

Johnson & Johnson Viewpoint

The company has a firm objective of creating a healthier and eco-friendly world. They wish to achieve it by 2025 with a blend of technology, affection, and creativity and deeply modify the curve of health for mankind.

Disclaimer: The author has been particularly focused while developing this content with a set objective of creating an exhaustive resource to assist keen individuals to have a bird’s eye view of the happenings of the fast-changing commercial world. Undoubtedly, it is an excellent break for both professionals and students to gather knowledge. If you solemnly follow this category of content, it will give you the platform to develop the skills needed to take your career to the next level. However, don’t make any hasty decisions that might create a mess with your finances. Be logical with your investment choices since it’s your hard-earned money. Any imprudent decision is detrimental to your finances. Constantly talk to your investment advisor to reach a dependable investment decision.

Latest news

Kiara Dawson
Kiara Dawson comes from an Engineering background, with a specialization in Information Technology. She has a keen interest and expertise in Web Development, Data Analytics, and Research. She trusts in the process of growth through knowledge and hard work.

Read Also

- Advertisement -


Please enter your comment!
Please enter your name here

Business Upside eMagazine
Business Upside eMagazine
Business Upside eMagazine